Cost Resulting from Anti-Tuberculosis Drug Shortages in the United States: A Hypothetical Cohort Study
about
Correction: Cost Resulting from Anti-Tuberculosis Drug Shortages in the United States: A Hypothetical Cohort StudyA systematic synthesis of direct costs to treat and manage tuberculosis disease applied to California, 2015.Antimicrobial Agent Shortages: The New Norm for Infectious Diseases Physicians.
P2860
Cost Resulting from Anti-Tuberculosis Drug Shortages in the United States: A Hypothetical Cohort Study
description
2015 nî lūn-bûn
@nan
2015 թուականին հրատարակուած գիտական յօդուած
@hyw
2015 թվականին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Cost Resulting from Anti-Tuber ...... s: A Hypothetical Cohort Study
@ast
Cost Resulting from Anti-Tuber ...... s: A Hypothetical Cohort Study
@en
Cost Resulting from Anti-Tuber ...... s: A Hypothetical Cohort Study
@nl
type
label
Cost Resulting from Anti-Tuber ...... s: A Hypothetical Cohort Study
@ast
Cost Resulting from Anti-Tuber ...... s: A Hypothetical Cohort Study
@en
Cost Resulting from Anti-Tuber ...... s: A Hypothetical Cohort Study
@nl
prefLabel
Cost Resulting from Anti-Tuber ...... s: A Hypothetical Cohort Study
@ast
Cost Resulting from Anti-Tuber ...... s: A Hypothetical Cohort Study
@en
Cost Resulting from Anti-Tuber ...... s: A Hypothetical Cohort Study
@nl
P2093
P2860
P1433
P1476
Cost Resulting from Anti-Tuber ...... s: A Hypothetical Cohort Study
@en
P2093
James C Scott
Jennifer Flood
Travis Porco
P2860
P304
P356
10.1371/JOURNAL.PONE.0134597
P407
P577
2015-01-01T00:00:00Z